Exelixis (NASDAQ:EXEL) Stock Price Expected to Rise, Barclays Analyst Says
Exelixis (NASDAQ:EXEL – Free Report) had its price target increased by Barclays from $25.00 to $29.00 in a report released on Thursday morning,Benzinga reports. They currently have an equal weight rating on the biotechnology company’s stock. A number of other equities research analysts have also commented on the company. Brookline Capital Management started coverage on […]
Exelixis (NASDAQ:EXEL – Free Report) had its price target increased by Barclays from $25.00 to $29.00 in a report released on Thursday morning,Benzinga reports. They currently have an equal weight rating on the biotechnology company’s stock. A number of other equities research analysts have also commented on the company. Brookline Capital Management started coverage on […]
